Sanford C. Bernstein
https://www.bernsteinresearch.comSanford C. Bernstein, a division of AllianceBernstein, is a research firm.
View Older Stories View More Recent Stories
-
Lindt's price hikes drive yearly sales beat
-
Form 4 WRAP TECHNOLOGIES, INC. For: Jan 12 Filed by: Bernstein Bruce
-
Bernstein names top internet stock picks to start the year
-
5 U.S. chip stocks to buy in 2026: Bernstein
-
Form 13F-HR Silverberg Bernstein For: Dec 31
-
FEI-Zyfer Announces Contract Awards for Approximately $6.0 Million
-
Patmos Secures $100 Million C-PACE Loan to Complete AI Data Center in Kansas City
-
Bernstein on Okta, Inc (OKTA): 'Best Immediate Idea?'
-
Zillow Group (ZG) PT Lowered, but Bernstein 'Remains Constructive On the Name'
-
'Our Top Pick Is Beam Therapeutics Inc (BEAM)'; PT Raised at Bernstein
-
Bernstein Reiterates Outperform Rating on Live Nation Entertainment (LYV) and TKO Group (TKO)
-
Analysts initiate Medline with bullish ratings after blockbuster IPO
-
OBI Pharma and TegMine Therapeutics Sign Exclusive Global License Agreement for Glycan-Targeting ADC
-
Bernstein SocGen Group Upgrades Vertex (VRTX) to Outperform
-
Bernstein names best cruise stock to buy in 2026
-
5 big analyst AI moves: ASML top semis pick for 2026, Adobe downgraded
-
Bernstein SocGen Group Upgrades Liberty Formula One (FWONK) to Outperform
-
Bernstein SocGen Group Starts Medline Inc (MDLN) at Outperform
-
Bernstein SocGen Group Downgrades Associated British Foods (ABF:LN) (ASBFY) to Market Perform
-
Bernstein SocGen Group Upgrades Next Plc. (NXT:LN) (NXGPY) to Outperform
-
Berstein sees a buying opportunity in this Air Tech stock
-
Stella Adler Foundation Reading of ‘All The President’s Men’ Sells Out With Cast Including: Mark Ruffalo, Ethan Hawke, Amy Brenneman, Don Cheadle, Kaley Cuoco, Laurence Fishburn, Spencer Garrett
-
This stock is Bernstein preferred name as oil choppy in 2026
-
Form 4 Maze Therapeutics, Inc. For: Jan 07 Filed by: Bernstein Harold
-
Trump pushes 'drill baby drill' agenda to Venezuela, hurts producers at home
-
Rule 10b-5 Securities Class Action Settlements Double During Second Half of 2025
-
Bernstein: Softening Safety Net Cuts Signal Tailwinds for Medicaid and Marketplace Names (CNC, MOH, ELV)
-
Bernstein SocGen Group Reiterates Outperform Rating on Ferrari (RACE)
-
Bernstein Highlights Top U.S. Medtech 2026 Picks: 'Sector Poised For a Rebound'
-
Bernstein on The Simply Goods Group (SMPL): 'Good Time to Be Loading Up'
-
Constellation Brands (STZ) PT Raised to $197 at Bernstein
-
Bernstein Comments on Broadcom Limited (AVGO) Post Meet: 'We came away with more conviction than ever'
-
This is the best European business services stock to buy in 2026: Bernstein
-
Bernstein’s top picks in Japan semiconductor as industry to see AI upcycle in 2026
-
Merck urges science-led US vaccine schedule after CDC trims childhood vaccine list
-
3 best Payments/Fintech stocks to own for 2026: Bernstein
-
AB to Report Fourth Quarter 2025 Results on February 5, 2026
-
As Saks teeters, department stores bet on shopping experiences
-
Teachally Named 2026 Top EdTech for Curriculum and Instruction by District Administration
-
Manatt Welcomes Senior Health Care Finance Executive in Washington, D.C.
-
These 2 stocks are best positioned to benefit from higher uranium prices: analyst
-
Bernstein SocGen Group Upgrades Aeroports de Paris (ADP:FP) (ARRPY) to Market Perform
-
Bernstein on Ferguson Plc. (FERG): 'FY2026 Non-Residential Growth Profile Is Underappreciated'
-
Bernstein: 'Caterpillar (CAT) Jumps Into Agentic AI with Cat AI Assist'
-
Bernstein: 'This Is a Good Deal for Eli Lilly (LLY)'
-
Bernstein on Expedia (EXPE): 'We Would Not Buy the Stock Here'
-
Cameco Corporation (CCJ) PT Raised to $101 at Bernstein SocGen Group
-
Soitec appoints Infineon executive Laurent Remont as CEO
-
Bernstein SocGen Group Downgrades Solvay SA (SOLB:BB) (SOBS) to Market Perform
-
Bernstein on Arrowhead Pharma (ARWR): 'Obesity Data Meets Our Solid Win Scenario'
